“…The Simons VIP Consortium (2012).22q11.2 Deletion Syndrome | 22q | 18 | 17 | Inclusionary criteria included: (a) diagnosis of 22q11.2 deletion syndrome by Fluorescence In Situ Hybridization (FISH) testing or microarray, (b) 6–18 years of age, (c) English as the participant’s primary language, and (d) no history of permanent bilateral hearing loss. | Baylis and Shriberg (2018) |
Autism Spectrum Disorder | ASD | 42 | 42 | Inclusionary criteria included: (a) a previous diagnosis of autism, PDD-NOS, ASD, or Asperger syndrome from a qualified clinician; (b) full scale IQ ≥ 70; (c) mean length of utterance of at least 3.0, based on transcription of a 3–5 min conversational sample; (d) > 70% of words intelligible in the language sample; and (e) normal hearing and vision (or corrected with glasses) on standard screening. Exclusionary criteria included known craniofacial or neurological impairment or bilingual background. | Shriberg, Paul, Black, and van Santen (2011) |
Down syndrome | DS | 50 | 45 | Three samples of participants: (1) 29 participants, 10–18 years of age with a confirmed diagnosis of Trisomy 21 and no diagnosis of autism spectrum disorders; (2) 17 participants, 8–18 years of age, with a confirmed diagnosis of Trisomy 21 and no diagnosis of autism spectrum disorders; (3) 4 male participants, ages 13–20 years, with a confirmed diagnosis of Trisomy 21. | Wilson, Abbeduto, Camarata, and Shriberg (2019a; 2019b); Camarata, Yoder, and Camarata (2006); Davis, Camarata, and Camarata (2016) |
fragile X syndrome | FXS | 30 | 28 | Males ranging in age from 11–22 yrs. Inclusionary criteria: (a) DNA or cytogenetic confirmation of the syndrome; (b) speech as the primary means of communication; (c) no more than a mild hearing loss per Chapman, Schwartz, and Kay-Raining Bird (1991) criterion; (d) ability to complete all tests; (e) nonverbal IQs <70; (f) passed screening and follow-up psychologist assessment for ASD. | Abbeduto, Murphy, Cawthon, Richmond, Weissman, Karadottir, and O’Brien (2003); Abbeduto, Murphy, Kover, Giles, Karadottir, Amman, Bruno, Kim, Schroeder, Anderson, and Nollin (2008); Keller-Bell and Abbeduto (2007) |
Galactosemia | |
…”